GLTO
Galecto, Inc.NASDAQHealthcare$24.99-1.99%ClosedMarket Cap: $39.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.16
P/S
0.00
EV/EBITDA
5.94
DCF Value
$110.04
FCF Yield
-17.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-308.9%
ROA
-80.5%
ROIC
-15.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-27.4M | $-200.7M | $2.31 | — |
| FY 2025 | $0.00 | -Infinity% | $-36.6M | $-209.8M | $-3.98 | — |
| Q3 2025 | $0.00 | NaN% | $-3.2M | $-3.1M | $-2.36 | — |
| Q2 2025 | $0.00 | NaN% | $-3.4M | $-3.4M | $-2.60 | — |
| Q1 2025 | $0.00 | NaN% | $-2.6M | $-2.5M | $-1.92 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.7M | $-6.7M | $-5.83 | — |
| FY 2024 | $0.00 | NaN% | $-22.3M | $-21.4M | $-18.53 | — |
| Q3 2024 | $0.00 | NaN% | $-3.8M | $-3.9M | $-3.39 | — |
| Q2 2024 | $0.00 | NaN% | $-5.6M | $-5.3M | $-4.92 | — |
| Q1 2024 | $0.00 | -Infinity% | $-5.7M | $-5.5M | $-5.10 | — |
| Q4 2023 | $0.00 | NaN% | $-6.7M | $-6.5M | $-5.97 | — |
| FY 2023 | $0.00 | NaN% | $-39.9M | $-38.3M | $-36.08 | — |